Biologic and immunomodulatory properties of mesenchymal stromal cells derived from human pancreatic islets

References

• Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med. 1997;14(Suppl 5):S1–85.
   PubMedGoogle Scholar
• Bloomgarden ZT. Diabetes complications. Diabetes Care. 2004;27:1506–14.
   PubMed Web of Science ®Google Scholar
• Robertson RP, Davis C, Larsen J, Stratta R, Sutherland DE. Pancreas and islet transplantation for patients with diabetes. Diabetes Care. 2000;23:112–6.
   PubMed Web of Science ®Google Scholar
• Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, . Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. New Engl J Med. 2000;343:230–8.
   PubMed Web of Science ®Google Scholar
• Neidlinger NA, Odorico JS, Sollinger HW, Fernandez LA. Can ‘extreme’ pancreas donors expand the donor pool? Curr Opinion Organ Transplant. 2008;13:67–71.
   PubMedGoogle Scholar
• Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP, . International trial of the Edmonton protocol for islet transplantation. New Engl J Med. 2006;355:1318–30.
   PubMed Web of Science ®Google Scholar
• Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation. 1968; 6:230–47.
   PubMed Web of Science ®Google Scholar
• Battiwalla M, Hematti P. Mesenchymal stem cells in hematopoietic stem cell transplantation. Cytotherapy. 2009;11:503–15.
   PubMed Web of Science ®Google Scholar
• Moriscot C, de Fraipont F, Richard MJ, Marchand M, Savatier P, Bosco D, . Human bone marrow mesenchymal stem cells can express insulin and key transcription factors of the endocrine pancreas developmental pathway upon genetic and/or microenvironmental manipulation in vitro. Stem Cells. 2005;23:594–603.
   PubMed Web of Science ®Google Scholar
• Kadam SS, Sudhakar M, Nair PD, Bhonde RR. Reversal of experimental diabetes in mice by transplantation of neo-islets generated from human amnion-derived mesenchymal stromal cells using immuno-isolatory macrocapsules. Cytotherapy. 2010;12:982–91.
   PubMed Web of Science ®Google Scholar
• Phadnis SM, Joglekar MV, Dalvi MP, Muthyala S, Nair PD, Ghaskadbi SM, . Human bone marrow-derived mesenchymal cells differentiate and mature into endocrine pancreatic lineage in vivo. Cytotherapy. 2011;13:279–93.
   PubMed Web of Science ®Google Scholar
• Chang C, Niu D, Zhou H, Zhang Y, Li F, Gong F. Mesenchymal stromal cells improve hyperglycemia and insulin deficiency in the diabetic porcine pancreatic microenvironment. Cytotherapy. 2008;10:796–805.
   PubMed Web of Science ®Google Scholar
• Limbert C, Path G, Ebert R, Rothhammer V, Kassem M, Jakob F, . PDX1- and NGN3-mediated in vitro reprogramming of human bone marrow-derived mesenchymal stromal cells into pancreatic endocrine lineages. Cytotherapy. 2011;13:802–13.
   PubMed Web of Science ®Google Scholar
• Lee RH, Seo MJ, Reger RL, Spees JL, Pulin AA, Olson SD, . Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci USA. 2006;103:17438–43.
   PubMed Web of Science ®Google Scholar
• Phinney DG, Prockop DJ. Concise review. Mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair. Current views. Stem Cells. 2007;25:2896–902.
   PubMed Web of Science ®Google Scholar
• Horwitz EM, Dominici M. How do mesenchymal stromal cells exert their therapeutic benefit? Cytotherapy. 2008; 10:771–4.
   PubMed Web of Science ®Google Scholar
• Tolar J, Le Blanc K, Keating A, Blazar BR. Concise review. Hitting the right spot with mesenchymal stromal cells. Stem Cells. 2010;28:1446–55.
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Ringden O. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2005;11: 321–34.
   PubMed Web of Science ®Google Scholar
• Prockop DJ, Olson SD. Clinical trials with adult stem/progenitor cells for tissue repair: let's not overlook some essential precautions. Blood. 2007;109:3147–51.
   PubMed Web of Science ®Google Scholar
• Stagg J, Galipeau J. Immune plasticity of bone marrow-derived mesenchymal stromal cells. Handbk Exp Pharmacol. 2007;180:45–66.
   Google Scholar
• Kode JA, Mukherjee S, Joglekar MV, Hardikar AA. Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy. 2009;11: 377–91.
   PubMed Web of Science ®Google Scholar
• Le Blanc K. Mesenchymal stromal cells: tissue repair and immune modulation. Cytotherapy. 2006;8:559–61.
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Pittenger M. Mesenchymal stem cells: progress toward promise. Cytotherapy. 2005;7:36–45.
   PubMed Web of Science ®Google Scholar
• Sundin M, D’Arcy P, Johansson CC, Barrett AJ, Lonnies H, Sundberg B, . Multipotent mesenchymal stromal cells express FoxP3: a marker for the immunosuppressive capacity? J Immunother. 2011;34:336–42.
   PubMedGoogle Scholar
• Kim J, Hematti P. Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. Exp Hematol. 2009;37:1445–53.
   PubMed Web of Science ®Google Scholar
• Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood. 2007;110:3499–506.
   PubMed Web of Science ®Google Scholar
• Keating A. How do mesenchymal stromal cells suppress T cells? Cell Stem Cell. 2008;2:106–8.
   PubMed Web of Science ®Google Scholar
• Carlotti F, Zaldumbide A, Loomans CJ, van Rossenberg E, Engelse M, de Koning EJ, . Isolated human islets contain a distinct population of mesenchymal stem cells. Islets. 2010;2:164–73.
   PubMed Web of Science ®Google Scholar
• Davani B, Ikonomou L, Raaka BM, Geras-Raaka E, Morton RA, Marcus-Samuels B, . Human islet-derived precursor cells are mesenchymal stromal cells that differentiate and mature to hormone-expressing cells in vivo. Stem Cells. 2007;25:3215–22.
   PubMed Web of Science ®Google Scholar
• Karaoz E, Ayhan S, Gacar G, Aksoy A, Duruksu G, Okcu A, . Isolation and characterization of stem cells from pancreatic islet: pluripotency, differentiation potential and ultrastructural characteristics. Cytotherapy. 2010;12:288–302.
   PubMed Web of Science ®Google Scholar
• Hanson SE, Kim J, Johnson BH, Bradley B, Breunig MJ, Hematti P, . Characterization of mesenchymal stem cells from human vocal fold fibroblasts. Laryngoscope. 2010;120: 546–51.
   Google Scholar
• Chang D, Weljie A, Newton J. Leveraging latent information in NMR spectra for robust predictive models. Pac Symp Biocomput. 2007:115–26..
   PubMedGoogle Scholar
• Hasbold J, Gett AV, Rush JS, Deenick E, Avery D, Jun J, . Quantitative analysis of lymphocyte differentiation and proliferation in vitro using carboxyfluorescein diacetate succinimidyl ester. Immunol Cell Biol. 1999;77:516–22.
   PubMedGoogle Scholar
• Lyons AB, Hasbold J, Hodgkin PD. Flow cytometric analysis of cell division history using dilution of carboxyfluorescein diacetate succinimidyl ester, a stably integrated fluorescent probe. Methods Cell Biol. 2001;63:375–98.
   PubMed Web of Science ®Google Scholar
• Trivedi P, Hematti P. Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells. Exp Hematol. 2008;36:350–9.
   PubMedGoogle Scholar
• Uccelli A, Pistoia V, Moretta L. Mesenchymal stem cells: a new strategy for immunosuppression? Trends Immunol. 2007;28:219–26.
   PubMed Web of Science ®Google Scholar
• Keating A. Mesenchymal stromal cells. Curr Opin Hematol. 2006;13:419–25.
   PubMed Web of Science ®Google Scholar
• Prockop DJ. ‘Stemness’ does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs). Clinical Pharmacol Ther. 2007;82:241–3.
   PubMed Web of Science ®Google Scholar
• Deans RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol. 2000;28:875–84.
   PubMed Web of Science ®Google Scholar
• Dazzi F, Horwood NJ. Potential of mesenchymal stem cell therapy. Curr Opin Oncol. 2007;19:650–5.
   PubMed Web of Science ®Google Scholar
• Tolar J, Villeneuve P, Keating A. Mesenchymal stromal cells for graft-versus-host disease. Human Gene Ther. 2011;22: 257–62.
   PubMed Web of Science ®Google Scholar
• Abdi R, Fiorina P, Adra CN, Atkinson M, Sayegh MH. Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes. Diabetes. 2008;57:1759–67.
   PubMed Web of Science ®Google Scholar
• Berman DM, Willman MA, Han D, Kleiner G, Kenyon NM, Cabrera O, . Mesenchymal stem cells enhance allogeneic islet engraftment in nonhuman primates. Diabetes. 2010;59: 2558–68.
   PubMed Web of Science ®Google Scholar
• Hematti P. Role of mesenchymal stromal cells in solid organ transplantation. Transplant Rev. 2008;22:262–73.
   Google Scholar
• Woods EJ, Walsh CM, Sidner RA, Zieger MA, Lakey JR, Ricordi C, . Improved in vitro function of islets using small intestinal submucosa. Transplant Proc. 2004;36:1175–7.
   PubMedGoogle Scholar
• Jung EJ, Kim SC, Wee YM, Kim YH, Choi MY, Jeong SH, . Bone marrow-derived mesenchymal stromal cells support rat pancreatic islet survival and insulin secretory function in vitro. Cytotherapy. 2011;13:19–29.
   PubMed Web of Science ®Google Scholar
• Khoo SH, Al-Rubeai M. Metabolomics as a complementary tool in cell culture. Biotechnol App Biochem. 2007;47:71–84.
   PubMedGoogle Scholar
• Cuperlovic-Culf M, Barnett DA, Culf AS, Chute I. Cell culture metabolomics: applications and future directions. Drug Discov Today. 2010;15:610–21.
   PubMed Web of Science ®Google Scholar
• Arnaud-Dabernat S, Kritzik M, Kayali AG, Zhang YQ, Liu G, Ungles C, . FGFR3 is a negative regulator of the expansion of pancreatic epithelial cells. Diabetes. 2007;56: 96–106.
   PubMedGoogle Scholar
• Dichmann DS, Miller CP, Jensen J, Scott Heller R, Serup P. Expression and misexpression of members of the FGF and TGFbeta families of growth factors in the developing mouse pancreas. Dev Dynamics. 2003;226:663–74.
   PubMedGoogle Scholar
• Gittes GK. Developmental biology of the pancreas: a comprehensive review. Dev Biol. 2009;326:4–35.
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringden O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol. 2003;31:890–6.
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringden O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol. 2003;57:11–20.
   PubMed Web of Science ®Google Scholar
• Gotherstrom C, Ringden O, Tammik C, Zetterberg E, Westgren M, Le Blanc K. Immunologic properties of human fetal mesenchymal stem cells. Am J Obstet Gynecol. 2004;190:239–45.
   PubMedGoogle Scholar
• Najar M, Rouas R, Raicevic G, Boufker HI, Lewalle P, Meuleman N, . Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6. Cytotherapy. 2009;11:570–83.
   PubMed Web of Science ®Google Scholar